Clinical Trial Update: Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study [Phase 2]

View source ↗

Summary

A Phase II trial evaluating immune ablation with hematopoietic stem cell support in patients with systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Northwestern University | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED